Fiscal Frenzy readers and investors are probably tired of all news articles about the healthcare industry. The reason for all the hype is because the healthcare sector is a defensive sector and has huge growth potential. What many good healthcare stocks like WellPoint, Humana, or a United Health don’t have is a nice paying dividend and a high yield (this is incredibly necessary in the near future since it is a stable source of profit in hard fiscal times).  Medtronic is a strong health care company with plenty of room for growth and an excellent dividend.  A few days ago the Medtronics board approved an almost 10% increase in dividend as well as a 60 million dollar share buyback program. With a current yield of 2.47% and last quarter’s annual revenue rising 8% this stock has growth potential. Medtronic’s stands buy their 10% EPS growth outlook. Today there was new data that proves the effectiveness of a Medtronic insertable cardiac monitoring Atrial Fibrillation. AF, as it is known, is one of the most common heart rhythmic disorders. The huge percentage pop it gains when markets opened were reduced to a minimal level by the closing bell. With the 80 billion dollar cuts in healthcare research from pharmaceutical companies new technologies might replace new medicines. Increasing spending for medical equipment intern increasing profits for Medtronic shareholders.  Hence, it is evident that Medtronic’s both has short term and long term benefits that make it an excellent buy for the time being that you should take advantage of.